Phathom Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (PHAT)

92 filings reported holding PHAT - Phathom Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share as of Q2 2022.
Phathom Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (PHAT) has 81 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 26.9M shares of 69.6M outstanding shares and own 38.61% of the company stock.
Largest 10 shareholders include Frazier Life Sciences Management, L.P. (5.83M shares), Medicxi Ventures Management (Jersey) Ltd (2.45M shares), Invesco Ltd. (2.05M shares), Avidity Partners Management LP (1.92M shares), VANGUARD GROUP INC (1.88M shares), Ensign Peak Advisors, Inc (1.68M shares), BlackRock Inc. (1.58M shares), 683 Capital Management, LLC (1.44M shares), Abingworth LLP (1.44M shares), and JANUS HENDERSON GROUP PLC (1.09M shares).
This table shows the top 81 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.